Common Specialities
{{speciality.keyWord}}
Common Issues
{{issue.keyWord}}
Common Treatments
{{treatment.keyWord}}

Overview

Bladder cancer Urothelial carcinoma marker profile Test

Bladder cancer Urothelial carcinoma marker profile Test

In the urinary system, there occurs a type of cancer to which we call urothelial carcinoma. It comes under the category of bladder cancer and cancer of the urethra, urachus and ureter. The symptoms of this disorder are high blood pressure, anaemia, frequent urination, blood in urine, microscopic hematuria, fatigue, strong urge to urinate without voiding and painful urination. Markers (any compounds in urine meant for diagnosing cancer) are assigned to the type of cancer in the process of profiling. The test which detects urothelial carcinoma is termed as bladder cancer urothelial carcinoma marker profile.

The preparations which are done before this test are as follows.
• We should not go through this test during the period of menstruation.
• Loose fitting and comfortable clothes should be worn.
• Removal of hairpins, jewellery and other accessories before the test.
• Light food should be taken before the test
• Lots of fluid has to be drunk before the test.

The preparations which are done before this test are as follows.
• We should not go through this test during the period of menstruation.
• Loose fitting and comfortable clothes should be worn.
• Removal of hairpins, jewellery and other accessories before the test.
• Light food should be taken before the test
• Lots of fluid has to be drunk before the test.

This diagnosis includes five tests i.e. urine test, imaging tests, biopsy, Positron Emission Tomography and rectal and vaginal exams. In the Urine test, the urine sample is taken while urination in the toilet. Images are taken by using X-ray equipment in MRI, X-rays and CT scans carried out in imaging tests. In biopsy, urinary system’s suspected areas are detected. In positron emission tomography, CT scan and MRI are done. Malignant tumours are detected in rectal and vaginal exams.

Positive FISH results in the absence of other signs or symptoms of bladder cancer recurrence may be evidence of other urinary tract-related cancers (eg, ureter, urethra, renal, and/or prostate in males), and further patient follow-up may be helpful. Negative FISH results in the presence of other signs and symptoms of bladder cancer recurrence may need to be regarded as suspicious false-negative results; repeat testing may be indicated. Although the assay was designed to detect chromosome changes associated with most bladder cancers, there are some bladder cancers whose genetic changes are not targeted by this test.
Specimen
Urine
Volume
50 mL urine mixed with preservative in TCC Monitoring kit
Container
TCC Monitoring kit

Table of Content

What is Bladder cancer Urothelial carcinoma marker profile Test?
Preparation for Bladder cancer Urothelial carcinoma marker profile Test
Uses of Bladder cancer Urothelial carcinoma marker profile Test
Procedure for Bladder cancer Urothelial carcinoma marker profile Test
Limitations of Bladder cancer Urothelial carcinoma marker profile Test
Specimen Requirements
Lybrate Gaurantee
Lybrate Gaurantee